Metabolon and SYNLAB Group Form Commercialization Collaboration

 

RESEARCH TRIANGLE PARK, N.C., March 29, 2016 —  Metabolon, Inc., the global leader in metabolomics, announced today that it has entered into a commercialization collaboration for its Quantose™ IR diagnostic with SYNLAB Group, the leader in the European market for clinical laboratory services. This collaboration is a significant milestone in delivering Metabolon’s technology for precision medicine and diagnostics applications to international markets, which include Europe, Latin America and the Middle East.

Subscribe to get the latest news